[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Most children now have natural immunity", "description": "From ONS data\n\nNY\n\nDropping mask requirements for businesses\n\nVaccine in Children 6 Months Through 4 Years of Age\n\nhttps://www.businesswire.com/news/home/20220201006018/en/Pfizer-and-BioNTech-Initiate-Rolling-Submission-for-Emergency-Use-Authorization-of-Their-COVID-19-Vaccine-in-Children-6-Months-Through-4-Years-of-Age-Following-Request-From-U.S.-FDA\n\n3 \u00b5g dose\n\nWeek up to 5 February 2022\n\nEngland \u2013 2,824,700 people (1 in 19)\n\nWales \u2013 121,200 people (1 in 25)\n\nNorthern Ireland \u2013 145,600 people (1 in 13)\n\nScotland \u2013 211,300 people (1 in 25)\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights\n\nAt least two-thirds aged 8 to 11 years have COVID-19 antibodies\n\nW/E 17th January\n\n8 to 11 year olds\n\nBetween 63.3% and 72.7% would have tested positive for antibodies\n\n12 to 15 year olds\n\nBetween 90.2% and 93.3% would have tested positive\n\nCOVID-19 deaths in England and Wales drop\n\nWeek ending 28th January 2022 \n\nOf the 12,401 deaths registered in England and Wales, 1,385 mentioned \"novel coronavirus (COVID-19)\n\nLast week it was 1,484 deaths\n\nMore than half a million with long COVID for at least a year\n\n6 December 2021 to 2 January 2022\n\n2.1% of the UK population (1.3 million people) said they were living with long COVID\n\nOf those 42% said they had had it for at least a year\nFatigue (50%)\n\n35 to 69 years, females", "link": "https://www.youtube.com/watch?v=D6RsXN_Wars", "date_published": "2022-02-10 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Ivermectin trial, Oxford University", "description": "Ivermectin Arm of PRINCIPLE Trial Put on Hold?\n\nhttps://www.medpagetoday.com/special-reports/exclusives/96194\n\nMedPage Today, Merck\n\"concluded that the probability of ivermectin providing a potentially safe and efficacious treatment option for SARS-CoV-2 infection is low and have prioritized internal efforts towards the development of alternate candidates that provide a higher probability of success for the treatment of COVID-19.\"\n\"If clinical data emerge providing definitive evidence for a positive benefit-risk assessment of the use of ivermectin in COVID-19, we stand ready to provide our expertise and resources as needed,\"\n\nIvermectin, PRINCIPLE trial\n\nhttps://www.principletrial.org\n\nhttps://www.principletrial.org/news/ivermectin-to-be-investigated-as-a-possible-treatment-for-covid-19-in-oxford2019s-principle-trial\n\nhttps://www.principletrial.org/news\n\nProfessor Chris Butler, from the University Oxford\u2019s Nuffield Department of Primary Care Health Sciences, \n\nJoint Chief Investigator of the PRINCIPLE trial, said, \n\n\u2018Ivermectin is readily available globally, \n\nhas been in wide use for many other infectious conditions so it\u2019s a well-known medicine with a good safety profile, \n\nand because of the early promising results in some studies it is already being widely used to treat COVID-19 in several countries.\n\nInternational Standard Randomised Controlled Trial Number\n\nhttps://www.isrctn.com/ISRCTN86534580?q=ivermectin&filters=&sort=&offset=4&totalResults=25&page=1&pageSize=10&searchType=basic-search\n\nWhen is the study starting and how long is it expected to run for?\n\nMarch 2020 to September 2022\n\nFavipiravir\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713175/\n\nhttps://bnf.nice.org.uk/treatment-summary/influenza.html\n\nIvermectin\n\nhttps://bnf.nice.org.uk/drug/ivermectin.html\n\nA double blind trial\n\nIndependent Data Monitoring and Safety Committee\n\nWill pick up a signal for futility, superiority, or safety\n\nWill let the Trial Steering Committee know\n\nThen a final analysis can be conducted, followed by the release of results and data", "link": "https://www.youtube.com/watch?v=c9bgCG5WgTQ", "date_published": "2022-02-09 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]